Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / Common Stock, par value $0.0001
-
Shares outstanding
-
53,041,500
-
Number of holders
-
79
-
Total 13F shares, excl. options
-
19,154,562
-
Shares change
-
+2,881,260
-
Total reported value, excl. options
-
$497,359,320
-
Value change
-
+$81,154,271
-
Number of buys
-
59
-
Number of sells
-
26
-
Price
-
$25.98
Institutional Holders of Cardlytics, Inc. - Common Stock, par value $0.0001 (CDLX) as of Q2 2019
As of 30 Jun 2019 Cardlytics, Inc. - Common Stock, par value $0.0001 (CDLX) had 89 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 19,154,562 shares of stock of the company.
Largest 10 holders included FMR LLC, Polaris Venture Management Co. V, L.L.C., CAS Investment Partners, LLC, JENNISON ASSOCIATES LLC, Canaan Partners VIII LLC, FRONTIER CAPITAL MANAGEMENT CO LLC, BlackRock Inc., VANGUARD GROUP INC, CANNELL CAPITAL LLC, and Grantham, Mayo, Van Otterloo & Co. LLC.
This table shows 89 institutional shareholders of the security as of 30 Jun 2019.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.